Literature DB >> 31263210

Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring.

Audes D M Feitosa1,2,3, Marco A Mota-Gomes4,5, Weimar S Barroso6, Roberto D Miranda7, Eduardo C D Barbosa8, Rodrigo P Pedrosa2,3, Paula C Oliveira9, Camila L D M Feitosa2, Andréa A Brandão10, José L Lima-Filho1, Andrei C Sposito11, Antonio Coca12, Wilson Nadruz13,14.   

Abstract

The values used to define the presence of white-coat or masked blood pressure (BP) effects are arbitrary. The aim of this study was to investigate the accuracy of several cutoff points based on the difference between office and home BP (ΔBP) values to detect white-coat uncontrolled (WUCH) and masked uncontrolled (MUCH) hypertension, which are phenotypes with adverse prognoses, in a large cohort of treated hypertensive patients. This multicenter cross-sectional study included 6,049 treated hypertensive patients (40% males, mean age 59.1 ± 14.4 years) who underwent office and home BP monitoring. We compared the sensitivity, specificity, area under curve (AUC), and positive (PPV) and negative (NPV) predictive values of several ΔBP cutoffs to detect WUCH and MUCH. The 15/9 mmHg cutoff, which reflects a 1.0 standard deviation of the ΔBP, showed the best AUC (0.783, 95% CI = 0.772-0.794) for the detection of WUCH, particularly in individuals with office grade 1 hypertension (AUC = 0.811, 95% CI = 0.793-0.829). The -1/-1 mmHg cutoff, which considers all individuals who had lower systolic or diastolic BP levels in the office than at home, had the highest AUC (0.822, 95% CI = 0.808-0.836) for the detection of MUCH. Both cutoff values also had the best performances for identifying all patients with higher and lower office-than-home BP grades. In conclusion, the 15/9 and -1/-1 mmHg cutoffs showed the best performance for the detection of treated hypertensive patients with WUCH and MUCH, respectively, and therefore might be markers of significant white-coat and masked effects and could be useful for identifying preferential targets for more routine home BP measures.

Entities:  

Keywords:  Home blood pressure; Masked hypertension; White-coat hypertension

Mesh:

Year:  2019        PMID: 31263210     DOI: 10.1038/s41440-019-0298-3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  25 in total

1.  Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.

Authors:  Giuseppe Mancia; Rita Facchetti; Michele Bombelli; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

2.  Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.

Authors:  Elizabeth S Muxfeldt; Roberto Fiszman; Fabio de Souza; Bianca Viegas; Fernanda C Oliveira; Gil F Salles
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

3.  Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate.

Authors:  G Mancia; G Bertinieri; G Grassi; G Parati; G Pomidossi; A Ferrari; L Gregorini; A Zanchetti
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

4.  Racial Disparities in Risks of Stroke.

Authors:  Wilson Nadruz; Brian Claggett; Mir Henglin; Amil M Shah; Hicham Skali; Wayne D Rosamond; Aaron R Folsom; Scott D Solomon; Susan Cheng
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

5.  Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.

Authors:  Takeshi Fujiwara; Yuichiro Yano; Satoshi Hoshide; Hiroshi Kanegae; Kazuomi Kario
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

Review 6.  Clinical significance of stress-related increase in blood pressure: current evidence in office and out-of-office settings.

Authors:  Masanori Munakata
Journal:  Hypertens Res       Date:  2018-05-29       Impact factor: 3.872

7.  Widening Racial Differences in Risks for Coronary Heart Disease.

Authors:  Wilson Nadruz; Brian Claggett; Mir Henglin; Amil M Shah; Hicham Skali; Wayne D Rosamond; Aaron R Folsom; Scott D Solomon; Susan Cheng
Journal:  Circulation       Date:  2018-03-13       Impact factor: 29.690

8.  Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality.

Authors:  José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Ernest Vinyoles; Manuel Gorostidi; Juan J de la Cruz; Gema Ruiz-Hurtado; Julián Segura; Fernando Rodríguez-Artalejo; Bryan Williams
Journal:  N Engl J Med       Date:  2018-04-19       Impact factor: 91.245

Review 9.  Diurnal blood pressure changes.

Authors:  Kei Asayama; Michihiro Satoh; Masahiro Kikuya
Journal:  Hypertens Res       Date:  2018-05-23       Impact factor: 3.872

10.  Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study.

Authors:  Kate Lovibond; Sue Jowett; Pelham Barton; Mark Caulfield; Carl Heneghan; F D Richard Hobbs; James Hodgkinson; Jonathan Mant; Una Martin; Bryan Williams; David Wonderling; Richard J McManus
Journal:  Lancet       Date:  2011-08-23       Impact factor: 79.321

View more
  6 in total

1.  Using CNN and HHT to Predict Blood Pressure Level Based on Photoplethysmography and Its Derivatives.

Authors:  Xiaoxiao Sun; Liang Zhou; Shendong Chang; Zhaohui Liu
Journal:  Biosensors (Basel)       Date:  2021-04-13

2.  Discrepancies in the diagnosis of hypertension in adolescents according to available office and home high blood pressure criteria.

Authors:  Fabiana G A M Feitosa; Audes D M Feitosa; Marco A Mota-Gomes; Annelise M G Paiva; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Andréa A Brandão; Thiago S V Jardim; Paulo C B V Jardim; Arthur B M Feitosa; Maria V C Santos; José L Lima-Filho; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-09       Impact factor: 3.738

3.  Home Blood Pressure Monitoring and Blood Pressure Control in Treated Hypertensives.

Authors:  Andréa Araujo Brandão; Weimar Kunz Sebba Barroso; Audes Feitosa; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; Priscila Valverde de Oliveira Vitorino; Roberto Pozzan; Lucio Paulo Ribeiro; Abraham Epelman; Giovanni Alves Saraiva; Fabio Serra Silveira; Antônio Almeida Braga; Marco Mota Gomes
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667

Review 4.  Recommendations for home blood pressure monitoring in Latin American countries: A Latin American Society of Hypertension position paper.

Authors:  Raúl Villar; Ramiro A Sánchez; José Boggia; Ernesto Peñaherrera; Jesús Lopez; Weimar Sebba Barroso; Eduardo Barbosa; Leonardo Cobos; Rafael Hernández Hernández; José Andrés Octavio; José Z Parra Carrillo; Agustín J Ramírez; Gianfranco Parati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

5.  The impact of changing home blood pressure monitoring cutoff from 135/85 to 130/80 mmHg on hypertension phenotypes.

Authors:  Audes D M Feitosa; Marco A Mota-Gomes; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Andréa A Brandão; Fernando Nobre; Decio Mion; Celso Amodeo; José L Lima-Filho; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-06       Impact factor: 3.738

6.  Treated Hypertensive Patients Assessed by Home Blood Pressure Telemonitoring. TeleMRPA Study.

Authors:  Weimar Kunz Sebba Barroso; Audes Diógenes Magalhães Feitosa; Eduardo Costa Duarte Barbosa; Andréa Araujo Brandão; Roberto Dischinger Miranda; Priscila Valverde Oliveira Vitorino; Carlos Alberto Machado; Antônio Almeida Braga; Lúcio Paulo de Souza Ribeiro; Marco Antonio Mota-Gomes
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.